-
EP3655434
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3655434
| EP3655434 - MONO AND BISPECIFIC ANTIBODY BINDING TO HERG1 AND HERG1/INTEGRIN BETA 1 [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 15.03.2024 Database last updated on 10.07.2024 | |
| Former | Request for examination was made Status updated on 24.04.2020 | ||
| Former | The international publication has been made Status updated on 26.01.2019 | ||
| Former | unknown Status updated on 01.08.2018 | Most recent event Tooltip | 12.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Universita' Degli Studi di Firenze Piazza San Marco, 4 50121 Firenze / IT | For all designated states DI.V.A.L. Toscana S.R.L. Via Madonna del Piano 6 50019 Sesto Fiorentino / IT | [2020/22] | Inventor(s) | 01 /
ARCANGELI, Annarosa Via G. del Pian dei Carpini 96/1 50127 Firenze / IT | 02 /
DURANTI, Claudia Via Ghiberti 120 50065 Pontassieve / IT | 03 /
CARRARESI, Laura Via G. Cavalcanti 32 50133 Firenze / IT | 04 /
CRESCIOLI, Silvia Via delle Panche 40 50141 Firenze / IT | [2020/22] | Representative(s) | Valenza, Silvia, et al Notarbartolo & Gervasi S.p.A. Viale Achille Papa, 30 20149 Milano / IT | [N/P] |
| Former [2020/22] | Valenza, Silvia, et al Notarbartolo & Gervasi S.p.A. Corso di Porta Vittoria 9 20122 Milano / IT | Application number, filing date | 18742941.0 | 29.06.2018 | [2020/22] | WO2018EP67641 | Priority number, date | IT20170083637 | 21.07.2017 Original published format: IT201700083637 | [2020/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019015936 | Date: | 24.01.2019 | Language: | EN | [2019/04] | Type: | A1 Application with search report | No.: | EP3655434 | Date: | 27.05.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.01.2019 takes the place of the publication of the European patent application. | [2020/22] | Search report(s) | International search report - published on: | EP | 24.01.2019 | Classification | IPC: | C07K16/28, C07K16/30, A61P35/00 | [2020/22] | CPC: |
C07K16/28 (EP,EA,KR,US);
A61P35/00 (EP,EA,KR,US);
C07K16/2842 (EP,EA,KR,US);
C07K16/30 (EP,EA,KR);
A61K2039/505 (EP,EA,KR,US);
C07K2317/31 (EP,EA,KR,US);
C07K2317/56 (US);
C07K2317/622 (US);
C07K2317/626 (EP,EA,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/22] | Title | German: | AN HERG1 UND HERG1/INTEGRIN BETA 1 BINDENDE MONO- UND BISPEZIFISCHE ANTIKÖRPER | [2020/22] | English: | MONO AND BISPECIFIC ANTIBODY BINDING TO HERG1 AND HERG1/INTEGRIN BETA 1 | [2020/22] | French: | ANTICORPS MONO ET BISPÉCIFIQUE SE LIANT À HERG1 ET HERG1/INTÉGRINE BÊTA 1 | [2020/22] | Entry into regional phase | 21.02.2020 | National basic fee paid | 21.02.2020 | Designation fee(s) paid | 21.02.2020 | Examination fee paid | Examination procedure | 21.02.2020 | Examination requested [2020/22] | 21.02.2020 | Date on which the examining division has become responsible | 03.09.2020 | Amendment by applicant (claims and/or description) | 15.03.2024 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 29.06.2020 | Renewal fee patent year 03 | 30.11.2021 | Renewal fee patent year 04 | 13.05.2022 | Renewal fee patent year 05 | 12.05.2023 | Renewal fee patent year 06 | 12.06.2024 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.06.2021 | 04 M06 Fee paid on 30.11.2021 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO2016020483 (UNIV FIRENZE [IT], et al) [AD] 5-10,14-17 * the whole document *; | [I] - ZANIERI ET AL., "beta1integrin/hERG1 complex as a novel molecular target for antineoplastic therapy", ABCD CONGRESS 2011 RAVENNA, (20110908), page 58, XP002779496 [I] 1-4,11-17 * the whole document * | [I] - EPIGENTEK, "HERG1 Monoclonal Antibody [A12]", INTERNET CITATION, page 1, URL: http://www.epigentek.com/catalog/herg1-monoclonal-antibody-a12-p-3957.html?currency=gb&height=190&width=500&border=1&modal=true&random=1431503689546, (20150415), XP002739553 [I] 5-10,14-17 * the whole document * | [IA] - ANDREA BECCHETTI ET AL, "The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression", SCIENCE SIGNALING, US, (20170404), vol. 10, no. 473, doi:10.1126/scisignal.aaf3236, ISSN 1945-0877, page eaaf3236, XP055461474 [I] 5-10,14-17 * the whole document * [A] 1-4,11,12 DOI: http://dx.doi.org/10.1126/scisignal.aaf3236 | [T] - C DURANTI ET AL, "Po-317 a novel bispecific antibody to harness the herg1-[beta]1 macromolecular complex for cancer therapy.", TUMOUR ANGIOGENESIS, doi:10.1136/esmoopen-2018-EACR25.830, (20180629), pages A352.2 - A352, URL: https://esmoopen.bmj.com/content/3/Suppl_2/A352.2, XP055505546 [T] * the whole document * DOI: http://dx.doi.org/10.1136/esmoopen-2018-EACR25.830 | by applicant | IT1367861 | WO2016020483 | - BECCHETTI A. et al., Sci.Signaling, vol. 10, no. 473, page eaaf3236 | - ARROYO et al., J. Cell Biol., (19920000), vol. 117, no. 3, pages 659 - 670 | - MARTIN-PADURA et al., J. Biol. Chem., (19940000), vol. 269, no. 8, pages 6124 - 6132 |